MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2

MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2

Background/Aims: MiR-26a has been identified as a tumor suppressor in various tumors, but the relationship between miR-26a and the sensitivity of gastric cancer to chemotherapies has not been established. The present study was performed to investigate the effect of miR-26a on drug sensitivity in gas...

Full description

Bibliographic Details
Main Authors: Lan Wen, Fangzhi Cheng, Yanyan Zhou, Chunhua Yin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Cisplatin sensitivity
E2F2
gastric cancer
MiR-26a
neuroblastomaRAS viral (v-ras) oncogene homolog
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=5;spage=313;epage=319;aulast=Wen

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=5;spage=313;epage=319;aulast=Wen

Similar Items